搜索筛选:
搜索耗时6.8287秒,为你在为你在102,285,761篇论文里面共找到 54 篇相符的论文内容
类      型:
[期刊论文] 作者:Tatsuo Kanda, 来源:中国癌症研究:英文版 年份:2013
Niigata University Hospital is a regional center institution of cancer therapy where many patients with gastrointestinal stromal tumors(GISTs)are visiting t...
[期刊论文] 作者:Tatsuo Kanda,Shunichi Matsuoka, 来源:世界胃肠病学杂志:英文版 年份:2018
The number of patients with nonalcoholic fatty liver diseases(NAFLD)including nonalcoholic steatohepatitis(NASH),has been increasing.NASH causes cirrhosis and h...
[期刊论文] 作者:Akinobu Tawada, Tatsuo Kanda,, 来源:世界肝病学杂志:英文版(电子版) 年份:2015
Hepatitis B virus (HBV) persistently infects approximately350 million people, and approximately 600000 liverrelateddeaths are observed per year worldwide.HBV infe...
[期刊论文] 作者:Shingo Nakamoto, Tatsuo Kanda,, 来源:世界肝病学杂志:英文版(电子版) 年份:2015
Patients who are infected with hepatitis C virus (HCV)and also have advanced fibrosis or cirrhosis have beenrecognized as "difficult-to-treat" patients during an er...
[期刊论文] 作者:Tatsuo Kanda,Mitsuhiko Moriyam, 来源:世界胃肠病学杂志:英文版 年份:2017
Hepatitis C virus(HCV) infection induces steatosis and is accompanied by multiple metabolic alterations including hyperuricemia, reversible hypocholesterolemia...
[期刊论文] 作者:Tatsuo Kanda,Mitsuhiko Moriyama,, 来源:World Journal of Gastroenterology 年份:2017
Hepatitis C virus(HCV) infection induces steatosis and is accompanied by multiple metabolic alterations including hyperuricemia, reversible hypocholesterolemia...
[期刊论文] 作者:Tatsuo Miyamura,Tatsuo Kanda,M, 来源:世界肝病学杂志:英文版(电子版) 年份:2013
AIM:To examine the association between the interleukin 28B(IL-28B)genotype and treatment response in hepatitis C virus(HCV)-infected patients with persistently...
[期刊论文] 作者:Tatsuo Kanda,Shingo Nakamoto,O, 来源:世界病毒学杂志 年份:2015
In 2009,several groups reported that interleukin-28B(IL28B)genotypes are associated with the response to peginterferon plus ribavirin therapy for chronic hepati...
[期刊论文] 作者:Tatsuo Kanda,Shingo Nakamoto,S, 来源:世界免疫学杂志 年份:2013
[期刊论文] 作者:Tatsuo Kanda,Yu Sato,Kazuhito, 来源:世界胃肠肿瘤学杂志:英文版(电子版) 年份:2011
Gastric carcinoma is one of the malignancies that are most frequently associated with esophageal carcinoma.We describe herein our device for advanced esophageal...
[期刊论文] 作者:Takaaki Hanyu,Tatsuo Kanda,Ats, 来源:世界胃肠外科杂志:英文版(电子版) 年份:2010
Endobronchial metastasis(EBM) is a rare form of metas-tasis from extrapulmonary malignant tumors,although there are few reports of EBM from gastric cancer speci...
[期刊论文] 作者:Reina Sasaki, Tatsuo Kanda, Sh, 来源:世界肝病学杂志:英文版(电子版) 年份:2015
Chronic hepatitis C virus (HCV) infection can cause liver cirrhosis and hepatocellular carcinoma (HCC).Several studies have demonstrated that the eradicationof HCV...
[期刊论文] 作者:Tatsuo Kanda,Keizo Kato,Akihit, 来源:世界肝病学杂志:英文版(电子版) 年份:2013
AIM:To examine the epidemiological data,hematological safety and treatment responses of peginterferonalpha 2a plus ribavirin therapy for hepatitis C.METHODS:Bet...
[期刊论文] 作者:Yoshiyuki Ikeda,Tatsuo Kanda,S, 来源:世界胃肠外科杂志:英文版(电子版) 年份:2009
AIM:To elucidate the influence of liver cirrhosis(LC) on the prognosis of patients with gastric cancer(GC).METHODS:Of the 1347 GC patients who underwent curativ...
[期刊论文] 作者:Reina Sasaki,Tatsuo Kanda,Naoy, 来源:世界肝病学杂志:英文版(电子版) 年份:2018
The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to higher sustained virologic response (SVR)...
[期刊论文] 作者:Kaoru Sakamoto,Tatsuo Kanda,Ta, 来源:外科学(英文) 年份:2013
Purpose: The aims of this pilot study were to reveal the biological characteristics of serum I-FABP and explore its clinical utility as a biomarker in patients...
[期刊论文] 作者:Shingo Nakamoto,Tatsuo Kanda,S, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2014
Some direct-acting antiviral agents for hepatitis C virus(HCV),such as telaprevir and boceprevir have been available since 2011.It was reported that HCV NS5A is...
[期刊论文] 作者:Shin Ichi Kosugi,Tatsuo Kanda,, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2006
我们这里从被由氟尿嘧啶和 nedaplatin 组成的联合化疗开始对待的食道的癌与肺转移报导一个 51 岁的人的一个案例。因为变形疾病消失了,抢救食管切除术被执行。尽管胸壁复发在...
[期刊论文] 作者:Xia Jiang,Tatsuo Kanda,Shuang, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2014
Hepatitis B virus(HBV)chronically infects more than350 million people worldwide.HBV causes acute and chronic hepatitis,and is one of the major causes of cirrhos...
[期刊论文] 作者:Tatsuo Kanda,Kazushige Nirei,N, 来源:世界胃肠病学杂志:英文版 年份:2017
The recent development of direct-acting antiviral agents(DAAs) against hepatitis C virus(HCV) infection could lead to higher sustained virological response(SVR)...
相关搜索: